Roger D. Klein, MD,JD (@RogerDKlein) is an expert in Health and Law with the Regulatory Transparency Project’s FDA and Health working group. He is a former Medical Director of Molecular Pathology at the Cleveland Clinic and former adviser to the FDA, CDC, HHS and CMS.
Astra Zeneca Vaccine. Interim data released by AstraZeneca on March 22 demonstrated 79 percent efficacy of its 2 dose recombinant DNA-based vaccine at preventing symptomatic COVID-19, which is lower than the over 90 percent efficacy reported by the Pfizer and Moderna vaccines on the identical metric.
Create your
podcast in
minutes
It is Free